Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02783625
Title Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Medical Center Stanford California 94305-5408 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
University of Washington School of Medicine in St. Louis Saint Louis Missouri 63110 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center Basking Ridge (Limited protocol activities) Basking Ridge New Jersey United States Details
Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Cancer Center @ Commack (Limitied protocol activities) Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester (Limited protocol activities) Harrison New York United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Nassau (Limited protocol activities) Uniondale New York 11553 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field